FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891825073> ?p ?o ?g. }

• W2891825073 endingPage "172" @default.
• W2891825073 startingPage "161" @default.
• W2891825073 abstract "Interactions between stromal cells and tumor cells pay a major role in cancer growth and progression. This is reflected in the composition of anticancer drugs which includes compounds directed towards the immune system and tumor-vasculature in addition to drugs aimed at the cancer cells themselves. Drug-based treatment regimens are currently designed to include compounds targeting the tumor stroma in addition to the cancer cells. Treatment limiting adverse effects remains, however, one of the major challenges for drug-based therapy and novel tolerable treatment modalities with diverse high efficacy on both tumor cells and stroma is therefore of high interest. It was hypothesized that the vascular targeted fusion toxin VEGF121/rGel in combination with the intracellular drug delivery technology photochemical internalization (PCI) stimulate direct cancer parenchymal cell death in addition to inhibition of tumor perfusion, and that an immune mediated response is relevant for treatment outcome. The aim of the present study was therefore to elucidate the anticancer mechanisms of VEGF121/rGel-PCI. In contrast to VEGF121/rGel monotherapy, VEGF121/rGel-PCI was found to mediate its effect through VEGFR1 and VEGFR2, and a targeted treatment effect was shown on two VEGFR1 expressing cancer cell lines. A cancer parenchymal treatment effect was further indicated on H&E stains of CT26-CL25 and 4 T1 tumors. VEGF121/rGel-PCI was shown, by dynamic contrast enhanced MRI, to induce a sustained inhibition of tumor perfusion in both tumor models. A 50% complete remission (CR) of CT26.CL25 colon carcinoma allografts was found in immunocompetent mice while no CR was detected in CT26.CL25 bearing athymic mice. In conclusion, the present report indicate VEGF121/rGel -PCI as a treatment modality with multimodal tumor targeted efficacy that should be further developed towards clinical utilization." @default.
• W2891825073 created "2018-09-27" @default.
• W2891825073 creator A5007488544 @default.
• W2891825073 creator A5009450447 @default.
• W2891825073 creator A5021481477 @default.
• W2891825073 creator A5023859224 @default.
• W2891825073 creator A5024811171 @default.
• W2891825073 creator A5027893444 @default.
• W2891825073 creator A5048281793 @default.
• W2891825073 creator A5056249790 @default.
• W2891825073 creator A5075259826 @default.
• W2891825073 creator A5084497572 @default.
• W2891825073 date "2018-10-01" @default.
• W2891825073 modified "2023-10-09" @default.
• W2891825073 title "Light-enhanced VEGF121/rGel: A tumor targeted modality with vascular and immune-mediated efficacy" @default.
• W2891825073 cites W1490814033 @default.
• W2891825073 cites W1543678657 @default.
• W2891825073 cites W1982937951 @default.
• W2891825073 cites W1993641358 @default.
• W2891825073 cites W2001615040 @default.
• W2891825073 cites W2008028087 @default.
• W2891825073 cites W2009314018 @default.
• W2891825073 cites W2015485124 @default.
• W2891825073 cites W2020709543 @default.
• W2891825073 cites W2020837536 @default.
• W2891825073 cites W2026599595 @default.
• W2891825073 cites W2028160054 @default.
• W2891825073 cites W2031770237 @default.
• W2891825073 cites W2032538996 @default.
• W2891825073 cites W2049298293 @default.
• W2891825073 cites W2053294422 @default.
• W2891825073 cites W2054050668 @default.
• W2891825073 cites W2054337672 @default.
• W2891825073 cites W2060420887 @default.
• W2891825073 cites W2062273647 @default.
• W2891825073 cites W2064905123 @default.
• W2891825073 cites W2069459218 @default.
• W2891825073 cites W2069717224 @default.
• W2891825073 cites W2070477834 @default.
• W2891825073 cites W2073432742 @default.
• W2891825073 cites W2074622849 @default.
• W2891825073 cites W2083209557 @default.
• W2891825073 cites W2088943828 @default.
• W2891825073 cites W2088990346 @default.
• W2891825073 cites W2090659632 @default.
• W2891825073 cites W2094912585 @default.
• W2891825073 cites W2098461639 @default.
• W2891825073 cites W2105807089 @default.
• W2891825073 cites W2107261030 @default.
• W2891825073 cites W2113272754 @default.
• W2891825073 cites W2143006986 @default.
• W2891825073 cites W2144944270 @default.
• W2891825073 cites W2154108863 @default.
• W2891825073 cites W2160112381 @default.
• W2891825073 cites W2165517578 @default.
• W2891825073 cites W2166156136 @default.
• W2891825073 cites W2177034134 @default.
• W2891825073 cites W2236857445 @default.
• W2891825073 cites W2292411590 @default.
• W2891825073 cites W2293809486 @default.
• W2891825073 cites W2345898210 @default.
• W2891825073 cites W2505262763 @default.
• W2891825073 cites W2516258544 @default.
• W2891825073 cites W2727270333 @default.
• W2891825073 cites W2752906572 @default.
• W2891825073 cites W2762550802 @default.
• W2891825073 cites W2790901981 @default.
• W2891825073 cites W8597972 @default.
• W2891825073 doi "https://doi.org/10.1016/j.jconrel.2018.09.005" @default.
• W2891825073 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30217739" @default.
• W2891825073 hasPublicationYear "2018" @default.
• W2891825073 type Work @default.
• W2891825073 sameAs 2891825073 @default.
• W2891825073 citedByCount "18" @default.
• W2891825073 countsByYear W28918250732019 @default.
• W2891825073 countsByYear W28918250732020 @default.
• W2891825073 countsByYear W28918250732021 @default.
• W2891825073 countsByYear W28918250732022 @default.
• W2891825073 crossrefType "journal-article" @default.
• W2891825073 hasAuthorship W2891825073A5007488544 @default.
• W2891825073 hasAuthorship W2891825073A5009450447 @default.
• W2891825073 hasAuthorship W2891825073A5021481477 @default.
• W2891825073 hasAuthorship W2891825073A5023859224 @default.
• W2891825073 hasAuthorship W2891825073A5024811171 @default.
• W2891825073 hasAuthorship W2891825073A5027893444 @default.
• W2891825073 hasAuthorship W2891825073A5048281793 @default.
• W2891825073 hasAuthorship W2891825073A5056249790 @default.
• W2891825073 hasAuthorship W2891825073A5075259826 @default.
• W2891825073 hasAuthorship W2891825073A5084497572 @default.
• W2891825073 hasConcept C121608353 @default.
• W2891825073 hasConcept C126322002 @default.
• W2891825073 hasConcept C16930146 @default.
• W2891825073 hasConcept C203014093 @default.
• W2891825073 hasConcept C2780394083 @default.
• W2891825073 hasConcept C502942594 @default.
• W2891825073 hasConcept C71924100 @default.
• W2891825073 hasConcept C8891405 @default.
• W2891825073 hasConcept C96232424 @default.

• next